AN2 Therapeutics, Inc.
ANTX • NASDAQ
AN2 Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Eric E. Easom, with a market cap of $131.5M.
Market Cap$131.5M
Employees36.0
CEOEric E. Easom
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
AN2 Therapeutics, Inc. FAQ
Common questions about AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026.
AN2 Therapeutics, Inc. has approximately 36 employees.